Laura T. Pizzi

Professor Laura T. Pizzi is a distinguished academic with a robust background in health policy and management, currently serving as a Professor and Director of the Health Outcomes, Policy, and Economics (HOPE) Program at Rutgers University's Ernest Mario School of Pharmacy. Her expertise lies in the intricate field of applied health economic and outcomes analyses, where she focuses on evaluating the economic implications and effectiveness of drugs and healthcare interventions. Her research is particularly centered on developing and assessing models of care tailored for older populations grappling with chronic diseases. This focus not only highlights her dedication to improving healthcare delivery for vulnerable groups but also underscores her commitment to enhancing the quality of life for these individuals through evidence-based practices. Professor Pizzi's methodological prowess in economic analyses is well-recognized, particularly in the areas of intervention costing and cost-effectiveness analysis. Her scholarly work has earned her numerous accolades, reflecting her significant contributions to the field of health economics. Her research has been instrumental in shaping healthcare policies and practices, ensuring that they are both economically viable and beneficial to patient outcomes. In addition to her research endeavors, Professor Pizzi plays an active role in the academic community through her involvement with editorial boards and councils related to pharmacoeconomics and outcomes research. Her participation in these platforms demonstrates her dedication to the advancement of healthcare practices and policies, as well as her commitment to fostering a collaborative environment for knowledge exchange and innovation. Her work not only contributes to the academic landscape but also has practical implications for healthcare systems, influencing policy decisions and the implementation of effective healthcare strategies. Professor Pizzi's contributions continue to pave the way for future advancements in health economics and outcomes research, making her a pivotal figure in the field.